Friday, September 11, 2020

ProSciento Finds Funding For Clinical Research

San Diego-based ProSciento, a clinical research organization (CRO) which focuses on non-alcoholic steatohepatitis (NASH), diabetes, obesity, and related metabolic diseases, has raised a round of funding, the company said this week. Size of the funding was not announced. According to ProSciento, the growth financing came from 1315 Capital. The company said it was advised by SVB Leerink in the transaction. ProSciento is led by Dr. Marcus Hompesch. The company says it the funds raised will support further expansion of the company's CRO operations and continued growth.

---